« Medical Homes in New York Hudson Valley | Main | NIH/FDA: Pluripotent cells in translation »

Feedback on creation of NIH's NCATS- advancing translational sciences

From today's NIH Feedback blog post by NIH Dir. Francis S. Collins, MD, PHD: an invitation to listen/participate in a webinar- March 16 at 4pm- he will speak to the community about his vision for NCATS ( the proposed National Center for Advancing Translational Sciences) (1). The 1-hr. webinar is hosted by the nonprofit organization FasterCures. see info. link below.
Read in Feedback posts (1)
-about the recent Scientific Management Review Board (SMRB) public teleconference about NIH activities related to the creation of NCATS. The Board heard from members of the public and from the chairs of the NIH working groups that have been charged with providing guidance on the proposed reorganization. Read the teleconference transcript linked there (46pp)
-about the Dec. 7, 2010, the SMRB recommendation that NIH realign its resources to establish a new Center devoted to advancing translational sciences. The action came in response to NIH Director's charge to the SMRB to formulate/recommend a plan for achieving optimal organization for therapeutic development within NIH.
A few excerpts from NCATS FAQS (2):
-The proposed Center would be formed initially by integrating selected translational research programs now located within the National Human Genome Research Institute (NHGRI), the National Center for Research Resources (NCRR), and the NIH Director's Common Fund.
-In addition to strengthening and streamlining the process of developing small-molecule compounds into drugs, the Center would support research aimed at accelerating the development of a full range of products and techniques for the diagnosis, treatment, and prevention of disease, including diagnostics, biologics, medical devices, and behavioral interventions.
-The central role of the proposed Center would be to establish and provide focused, integrated, and systematic approaches for building new bridges that link basic discovery research with therapeutics development and clinical care.
Read more about the scientific rationale, benefit to the public, proposed organization, logistics and public input, and impact on portfolio research and impact on employees.
(1) http://feedback.nih.gov/ NIH's Feedback is a virtual space for input from individuals across NIH and the broader community on important NIH initiatives as well as issues that affect NIH, the biomedical research community, and human health in general. see current and archived posts
(2)http://feedback.nih.gov/index.php/faq-ncats/

Post a comment

(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)

About

This page contains a single entry from the blog posted on March 10, 2011 1:12 PM.

The previous post in this blog was Medical Homes in New York Hudson Valley.

The next post in this blog is NIH/FDA: Pluripotent cells in translation.

Many more can be found on the main index page or by looking through the archives.